You are currently viewing a new version of our website. To view the old version click .
  • 1.8Impact Factor
  • 24 daysTime to First Decision

Pharmacy, Volume 13, Issue 3

June 2025 - 31 articles

Cover Story: Most prescription opioids primarily target the mu receptor. Tapentadol is a mu agonist and monoamine reuptake inhibitor. An advantage of tapentadol over traditional opioids includes higher efficacy in managing neuropathic pain. This study explored the patterns in tapentadol’s use in the US by using three complementary databases, including the Automation of Reports and Consolidated Orders System, Medicaid, and Medicare Part D programs. Tapentadol use decreased nationally between 2012 and 2020 by −53.8%, and prescriptions to Medicaid patients declined by −55.2% between the peak year (2011) and 2020. Distribution was over twice as high in southern relative to Pacific states. The substantial regional differences in tapentadol may warrant further attention by opioid stewardship programs. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (31)

  • Article
  • Open Access
1 Citations
1,160 Views
15 Pages

Pharmacists’ Perceptions of 3D Printing and Bioprinting as Part of Personalized Pharmacy: A Cross-Sectional Pilot Study in Bulgaria

  • Anna Mihaylova,
  • Antoniya Yaneva,
  • Dobromira Shopova,
  • Petya Kasnakova,
  • Stanislava Harizanova,
  • Nikoleta Parahuleva,
  • Rumyana Etova,
  • Ekaterina Raykova,
  • Mariya Semerdzhieva and
  • Desislava Bakova

Advances in pharmaceutical technology have positioned 3D printing and bioprinting as promising tools for developing personalized drug therapies. These innovations may redefine compounding practices by enabling precise, patient-specific drug formulati...

  • Article
  • Open Access
1,293 Views
12 Pages

Pharmacists’ Experiences on Adverse Drug Reactions in Saudi Arabia: A Cross-Sectional Study

  • Dalal Salem Bakheit Aldossari,
  • Naeema Taha Alshalaan,
  • Khuloud Salem Alshammari,
  • Fatima Ahmed Lubbad,
  • Mudhi Ratyan Alanazi,
  • Neamah Ahmed Lubbad,
  • Nada Suliman Fahad Alessa and
  • Sheraz Ali

Background and objectives: As part of Vision 2030, Saudi Arabia aims to strengthen its healthcare system by enhancing efficiency, reducing medical errors, and ensuring drug safety. Evidence on pharmacists’ experiences with adverse drug reaction...

  • Article
  • Open Access
694 Views
14 Pages

Application of Fuzzy AHP for Medication Decision Making in Iron-Chelating Medications for Thalassemia

  • Saeed Barzegari,
  • Hosein Rostamian,
  • Ehsan Firoozi-Majd and
  • Ibrahim Arpaci

Iron overload is a significant concern for patients with thalassemia and often necessitates the use of iron-chelating agents to mitigate the associated complications. Selecting the most appropriate chelation therapy from the available options is a co...

  • Article
  • Open Access
1,671 Views
12 Pages

Background/Objectives: Long-acting insulin glargine (iGlar) has been available as a biosimilar since 2014 in the UK. We reviewed previous prescribing to evaluate if the anticipated cost savings with biosimilars were realized with iGlar. Methods: This...

  • Article
  • Open Access
2,060 Views
10 Pages

Real-World Experience of L-Glutamine in Sickle Cell Disease: A Retrospective Observational Study

  • Shouq Turkistani,
  • Atika AlHarbi,
  • Mansoor Khan,
  • Aeshah AlAzmi,
  • Sultan Almutairi,
  • Naglla Elimam and
  • Sultan Alotaibi

Sickle cell disease (SCD) affects millions globally, with approximately 0.26% of the Saudi population impacted. Despite standard treatments, patients frequently experience vaso-occlusive crises (VOCs). This retrospective observational study evaluated...

  • Article
  • Open Access
1,637 Views
10 Pages

Real-World Evidence Assessing the Safety of Administering Intravenous Rituximab Biosimilar in the First Cycle and Subcutaneous Rituximab in Subsequent Cycles in B-Cell Lymphoma Patients

  • Tamather Almandeel,
  • Mansoor Ahmed Khan,
  • Ashwag Algethami,
  • Mashael S. Alaboud,
  • Munirah A. Alkathiri,
  • Mohammed Aseeri,
  • Ahmed Absi,
  • Mubarak Almansour and
  • Abdullah Alotaibi

Background: Biosimilar versions of rituximab have similar safety and efficacy as the reference product across all indications based on the extrapolation principle. Our organization replaced intravenous (IV) rituximab (Mabthera) with IV rituximab (Tru...

  • Article
  • Open Access
1,364 Views
11 Pages

Potentially inappropriate medications (PIMs) increase the risk of adverse drug reactions, hospitalizations, and worsened health outcomes in older adults, particularly those with cognitive impairment (CI) or dementia. This study was designed to compar...

  • Article
  • Open Access
1,233 Views
20 Pages

Objectives: To determine the willingness of Jamaican pharmacists to stock and dispense smoking cessation aids and determine barriers to selling products. Design: A descriptive study that utilized pharmacist-completed surveys. The participants receive...

  • Article
  • Open Access
2 Citations
1,520 Views
14 Pages

Qualitative Analysis of Test-to-Treat Benefits and Barriers for Pharmacists in Rural Washington State

  • Bradley Brown,
  • Megan Undeberg,
  • Angela Stewart and
  • Kimberly McKeirnan

Background: Rural communities in the United States experience significant barriers in accessing healthcare, including inadequate numbers of providers and local healthcare facilities. These barriers are exacerbated during seasons with high rates of re...

  • Article
  • Open Access
3,098 Views
17 Pages

Background: Self-medication is the use of medicinal products to treat self-diagnosed disorders or symptoms without the prescription or supervision of a healthcare professional. There is a lack of data about self-medication knowledge, attitudes, and p...

of 4

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmacy - ISSN 2226-4787Creative Common CC BY license